TY  - JOUR
AU  - Qu, Junyan
AU  - Liu, Xinyao
AU  - Quan, Min
AU  - Qiao, Fu
AU  - Bilal, Hazrat
AU  - Fang, Wenjie
AU  - Xu, Bin
AU  - Chen, Yijian
AU  - Liu, Jing
AU  - Peng, Hong
AU  - Pan, Jue
AU  - Gu, Li
AU  - Zhou, Zhihui
AU  - Yang, Wenjie
AU  - Ge, Ying
AU  - Zhang, Jingping
AU  - Li, Jiabin
AU  - Wang, Xiaopan
AU  - Wu, Anhua
AU  - Momin, Nek Wali Shah
AU  - Habib, Mohammad Daud
AU  - Manduzai, Ajmal Khan
AU  - Hanifi, Ahmed Nasir
AU  - Popal, Atifa
AU  - Samnang, Chin
AU  - Gemechu, Abdella
AU  - Mandal, Surajit De
AU  - Gaur, Pratibha
AU  - Kale, Pratibha
AU  - Gohel, Tejas
AU  - Hallur, Vinaykumar
AU  - Abbasi, Bahareh
AU  - Farshi, Susan
AU  - Ganji, Shahla Mohammad
AU  - Nasiri, Eisa
AU  - Jamaati, Hamid Reza
AU  - Than, Leslie Thian Lung
AU  - Amir, Afreenish
AU  - Khan, Rahat Ullah
AU  - Iqbal, Waheed
AU  - Mehmood, Irum
AU  - Nizamuddin, 
AU  - Rahman, Matiur
AU  - Rehman, Sijad Ur
AU  - Faryal, Rani
AU  - Bakhtiar, Syeda Marriam
AU  - Khan, Muhammad Nadeem
AU  - Liu, Wei
AU  - Zong, Zhiyong
PY  - 2026
TI  - Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections
JO  - iFungi
SP  - 9670007
VL  - 1
IS  - 1
AB  - The epidemiological patterns of respiratory viruses are complex and highly diverse. Infections caused particularly by SARS-CoV-2 and influenza viruses are frequently followed by secondary mucormycosis, posing significant challenges to clinical management and public health. To address the challenges posed by secondary mucormycosis following respiratory viral infections, the Fungal Prevention and Control Team of the Center for Infectious Diseases at West China Hospital, Sichuan University, convened experts from relevant disciplines across the world to develop the "Expert Consensus on the Prevention of Secondary Mucormycosis Following Respiratory Viral Infections". This consensus aims to provide systematic guidance and optimize prevention strategies. It identifies high-risk populations for mucormycosis after respiratory viral infections and offers 12 preventive recommendations focusing on four areas: education and training, personal protection, early diagnosis and treatment, and infection control. The document also highlights key measures that remain controversial or insufficiently supported by evidence and outlines directions for future research to promote greater awareness and research of mucormycosis.
UR  - https://doi.org/10.26599/iFungi.2026.9670007
DO  - 10.26599/iFungi.2026.9670007